SCHEMBL16596341

SCHEMBL16596341

COc1cc(NC(=O)CCCCCOc2cccc(Br)c2)ncn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 4/20 0.50
ERBB3 P21860 2/20 0.50
LMNA P02545 1/20 0.49
GAA P10253 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
ALDH1A1 P00352 3/20 0.47
KDM4E B2RXH2 2/20 0.47
HDAC1 Q13547 6/20 0.47
HDAC2 Q92769 5/20 0.47
HDAC3 O15379 3/20 0.47
HDAC6 Q9UBN7 3/20 0.47
KDR P35968 2/20 0.47
HDAC4 P56524 2/20 0.47
HDAC7 Q8WUI4 2/20 0.47
HDAC10 Q969S8 2/20 0.47
HDAC11 Q96DB2 2/20 0.47
HDAC8 Q9BY41 2/20 0.47
HDAC9 Q9UKV0 2/20 0.47
HDAC5 Q9UQL6 2/20 0.47
CNR1 P21554 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18328512 0.87 EGFR (0.52) EGFRERBB3LMNAGAAL3MBTL1
SCHEMBL16596342 0.86 ALDH1A1 (0.58) LMNAGAAL3MBTL1ALDH1A1KDM4E
SCHEMBL18332927 0.83 LMNA (0.54) LMNAGAAL3MBTL1ALDH1A1KDM4E
SCHEMBL16596198 0.83 LMNA (0.54) LMNAGAAL3MBTL1ALDH1A1KDM4E
SCHEMBL16596340 0.83 LMNA (0.54) LMNAGAAL3MBTL1ALDH1A1KDM4E
SCHEMBL18332921 0.82 LMNA (0.55) LMNAGAAL3MBTL1ALDH1A1KDM4E
SCHEMBL16596278 0.82 CNR1 (0.48) EGFRLMNAGAAL3MBTL1ALDH1A1
SCHEMBL16596175 0.80 ALDH1A1 (0.47) EGFRERBB3LMNAGAAL3MBTL1
SCHEMBL18328516 0.80 LMNA (0.47) LMNAGAAL3MBTL1ALDH1A1KDM4E
SCHEMBL16596237 0.79 LMNA (0.59) LMNAGAAL3MBTL1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9751851-B2 Molecules and compositions that inhibit gram negative bacteria and their uses THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2017-09-05 US disclosed
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2016-12-22 US disclosed
WO-2015042363-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 2015-03-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160368892-A1 MOLECULES AND COMPOSITIONS THAT INHIBIT GRAM NEGATIVE BACTERIA AND THEIR USES BLVRB, PGLS, GRHPR EGFR 1009/4885ERBB3 2502/4885LMNA 4678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.